Close Menu

NEW YORK – The US Food and Drug Administration on Monday granted Emergency Use Authorization to Abbott Laboratories for the company's AdviseDx SARS-CoV-2 IgG II test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.